LGC Overview
- Year Founded
-
1842
- Status
-
Private
- Employees
-
4,000
- Latest Deal Type
-
Debt Refin.
- Financing Rounds
-
20
- Investments
-
35
LGC General Information
Description
Provider of scientific testing, specialist analytical and diagnostic laboratory services across the human healthcare and applied market segments. The company offers a full range of genomic analysis and measurement tools as well as supply chain quality insurance which are typically embedded and recurring within customers' products and workflows and are valued for their performance, quality and range, enabling clients to improve innovation in nucleic acid therapies and cancer screening.
Contact Information
Website
www.lgcgroup.comCorporate Office
- The Priestley Building
- 10 Priestley Road
- Guildford GU2 7XY
- England, United Kingdom
Corporate Office
- The Priestley Building
- 10 Priestley Road
- Guildford GU2 7XY
- England, United Kingdom
LGC Timeline
LGC Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
LGC Comparisons
Industry
Financing
Details
LGC Competitors (2)
One of LGC’s 2 competitors is Eurofins Scientific, a Corporation company based in Luxembourg, Luxembourg.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Eurofins Scientific | Corporation | Luxembourg, Luxembourg | ||||
| Eurofins Genomics Europe Shared Services | Corporation | Ebersberg, Germany |
LGC Patents
LGC Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025233633-A1 | Method for selection of cells with reparative potential | Pending | 10-May-2024 | ||
| WO-2021023968-A1 | An aspirate-dispense apparatus and associated methods | Inactive | 02-Aug-2019 | ||
| AU-2014313926-A1 | Oligonucleotides comprising a secondary structure and uses thereof | Inactive | 27-Aug-2013 | ||
| CA-2921973-A1 | Oligonucleotides comprising a secondary structure and uses thereof | Inactive | 27-Aug-2013 | ||
| EP-3039160-A1 | Oligonucleotides comprising a secondary structure and uses thereof | Active | 27-Aug-2013 | C12Q1/6876 |
LGC Signals
LGC Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
LGC Investments (35)
LGC’s most recent deal was a Buyout/LBO with Niagen Bioscience (ChromaDex Reference Standards Business). The deal was made on 24-Feb-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Niagen Bioscience (ChromaDex Reference Standards Business) | 24-Feb-2026 | Buyout/LBO | Other Chemicals and Gases | ||
| DiaMex (Devices and Supplies) | 04-Dec-2024 | Buyout/LBO | Other Devices and Supplies | ||
| Virusys | 30-Sep-2023 | Buyout/LBO | Drug Discovery | ||
| Kova International | 24-Jul-2023 | Buyout/LBO | Diagnostic Equipment | ||
| Lipomed (Reference Standards Business) | 17-Feb-2023 | Buyout/LBO | BPO/Outsource Services |
LGC Exits (2)
LGC’s most recent exit was on 21-Dec-2020 from Safefood 360. The exit was categorized as with 5 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Safefood 360 | 21-Dec-2020 | Completed |
|
||
| SeraCare | 26-Nov-2018 | Buyout/LBO | Completed |
|
LGC Affiliates
Subsidiaries (15)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| DiaMex (Devices and Supplies) | Heidelberg, Germany | 2011 | |
| The Native Antigen Company | Guildford, United Kingdom | 2010 | |
| Douglas Scientific | Alexandria, MN | 2009 | |
| HFL Sport Science | United Kingdom | 2007 | |
| Technopath Clinical Diagnostics | Ballina, Ireland | 2004 |
LGC FAQs
-
When was LGC founded?
LGC was founded in 1842.
-
Where is LGC headquartered?
LGC is headquartered in Guildford, United Kingdom.
-
What is the size of LGC?
LGC has 4,000 total employees.
-
What industry is LGC in?
LGC’s primary industry is Laboratory Services (Healthcare).
-
Is LGC a private or public company?
LGC is a Private company.
-
What is LGC’s current revenue?
The current revenue for LGC is .
-
How much funding has LGC raised over time?
LGC has raised $1.5B.
-
Who are LGC’s investors?
Omnes Capital, Abu Dhabi Investment Authority, Astorg, and Cinven have invested in LGC.
-
Who are LGC’s competitors?
Eurofins Scientific and Eurofins Genomics Europe Shared Services are competitors of LGC.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process